Contact tracing to control infectious disease: when enough is enough

Contact tracing (also known as partner notification) is a primary means of controlling infectious diseases such as tuberculosis (TB), human immunodeficiency virus (HIV), and sexually transmitted diseases (STDs). However, little work has been done to determine the optimal level of investment in contact tracing. In this paper, we present a methodology for evaluating the appropriate level of investment in contact tracing. We develop and apply a simulation model of contact tracing and the spread of an infectious disease among a network of individuals in order to evaluate the cost and effectiveness of different levels of contact tracing. We show that contact tracing is likely to have diminishing returns to scale in investment: incremental investments in contact tracing yield diminishing reductions in disease prevalence. In conjunction with a cost-effectiveness threshold, we then determine the optimal amount that should be invested in contact tracing. We first assume that the only incremental disease control is contact tracing. We then extend the analysis to consider the optimal allocation of a budget between contact tracing and screening for exogenous infection, and between contact tracing and screening for endogenous infection. We discuss how a simulation model of this type, appropriately tailored, could be used as a policy tool for determining the appropriate level of investment in contact tracing for a specific disease in a specific population. We present an example application to contact tracing for chlamydia control.

[1]  Matt J Keeling,et al.  Contact tracing and disease control , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[2]  Charles Reveller,et al.  An Optimization Model of Tuberculosis Epidemiology , 1969 .

[3]  H. Ward,et al.  SEXUAL NETWORKS AND THE TRANSMISSION OF HIV IN LONDON , 1998, Journal of Biosocial Science.

[4]  David L. Craft,et al.  Emergency response to a smallpox attack: The case for mass vaccination , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Catherine H Mercer,et al.  Scale-Free Networks and Sexually Transmitted Diseases: A Description of Observed Patterns of Sexual Contacts in Britain and Zimbabwe , 2004, Sexually transmitted diseases.

[6]  Travis C Porco,et al.  Logistics of community smallpox control through contact tracing and ring vaccination: a stochastic network model , 2004, BMC Public Health.

[7]  A. Nizam,et al.  Containing Bioterrorist Smallpox , 2002, Science.

[8]  G. Oxman,et al.  A Comparison of the Case‐Finding Effectiveness and Average Costs of Screening and Partner Notification , 1996, Sexually transmitted diseases.

[9]  MEDICAL EXAMINATIONS. , 1919, California state journal of medicine.

[10]  G S Zaric,et al.  Resource allocation for epidemic control over short time horizons. , 2001, Mathematical biosciences.

[11]  Johannes Müller,et al.  Optimal Vaccination Patterns in Age-Structured Populations , 1998, SIAM J. Appl. Math..

[12]  Roger I Glass,et al.  Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[13]  J. Wylie,et al.  Patterns of Chlamydia and Gonorrhea Infection in Sexual Networks in Manitoba, Canada , 2001, Sexually transmitted diseases.

[14]  Duncan J. Watts,et al.  Collective dynamics of ‘small-world’ networks , 1998, Nature.

[15]  J Clarke,et al.  Contact tracing for chlamydia: data on effectiveness , 1998, International journal of STD & AIDS.

[16]  S. Goldie,et al.  Screening for Chlamydia trachomatis in Women 15 to 29 Years of Age: A Cost-Effectiveness Analysis , 2004, Annals of Internal Medicine.

[17]  G. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[18]  J. Potterat,et al.  Social networks and infectious disease: the Colorado Springs Study. , 1994, Social science & medicine.

[19]  GLOBAL PREVALENCE AND INCIDENCE OF SELECTED CURABLE SEXUALLY TRANSMITTED DISEASES: OVERVIEW AND ESTIMATES , 2000 .

[20]  K Dietz,et al.  Contact tracing in stochastic and deterministic epidemic models. , 2000, Mathematical biosciences.

[21]  MSc Douglas K. Owens MD,et al.  Interpretation of cost-effectiveness analyses , 2007, Journal of General Internal Medicine.

[22]  T. Farley,et al.  Comparing the Cost-Effectiveness of HIV Prevention Interventions , 2004, Journal of acquired immune deficiency syndromes.

[23]  A. Haddix,et al.  Partner Notification to Prevent Pelvic Inflammatory Disease in Women: Cost‐Effectiveness of Two Strategies , 1997, Sexually transmitted diseases.

[24]  Benjamin Armbruster,et al.  Optimal mix of screening and contact tracing for endemic diseases. , 2007, Mathematical biosciences.

[25]  I. Longini,et al.  An optimization model for influenza A epidemics , 1978 .

[26]  Atlanta,et al.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[27]  S. Helleringer,et al.  The Likoma Network Study: Context, data collection, and initial results. , 2009, Demographic research.

[28]  C. Fraser,et al.  Reducing the impact of the next influenza pandemic using household-based public health interventions. , 2006, Hong Kong medical journal = Xianggang yi xue za zhi.

[29]  Ramon Huerta,et al.  Contact tracing and epidemics control in social networks. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.

[30]  K. Dasgupta,et al.  Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. , 2000, American journal of respiratory and critical care medicine.

[31]  M. R. Howell,et al.  Cost-Effectiveness of Five Strategies for Gonorrhea and Chlamydia Control Among Female and Male Emergency Department Patients , 2002, Sexually transmitted diseases.

[32]  Margaret L Brandeau,et al.  Dynamic resource allocation for epidemic control in multiple populations. , 2002, IMA journal of mathematics applied in medicine and biology.

[33]  W. Raub.  From the National Institutes of Health. , 1990, JAMA.

[34]  K. Hupfeld,et al.  Program evaluation. , 1989, NLN publications.

[35]  David R. Holtgrave,et al.  Cost-effectiveness of counseling and testing and partner notification: a decision analysis. , 1999, AIDS.

[36]  I. Kiss,et al.  Disease contact tracing in random and clustered networks , 2005, Proceedings of the Royal Society B: Biological Sciences.

[37]  Sally C Morton,et al.  A model for a smallpox-vaccination policy. , 2003, The New England journal of medicine.

[38]  Herbert W. Hethcote,et al.  Gonorrhea modeling: a comparison of control methods , 1982 .

[39]  J. Potterat,et al.  Epidemiologic differences between chlamydia and gonorrhea. , 1990, American journal of public health.

[40]  K. Holmes,et al.  Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. , 2007, MMWR. Morbidity and mortality weekly report.

[41]  J. Hyman,et al.  Modeling the impact of random screening and contact tracing in reducing the spread of HIV. , 2003, Mathematical biosciences.

[42]  M. Kretzschmar,et al.  Sexual Network Structure and Sexually Transmitted Disease Prevention: A Modeling Perspective , 2000, Sexually transmitted diseases.

[43]  J C Jager,et al.  Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. , 2000, Sexually transmitted diseases.

[44]  S. Borgatti,et al.  Social Networks of Drug Users in High-Risk Sites: Finding the Connections , 2002, AIDS and Behavior.

[45]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[46]  L. Tanoue.  Extensively Drug-Resistant Tuberculosis—United States, 1993–2006 , 2008 .

[47]  W. Levine,et al.  SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES 2002 , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[48]  A. Johnson,et al.  The role and effectiveness of partner notification in STD control: a review. , 1996, Genitourinary medicine.

[49]  Hyatt Dulles Airport.  Scientific Evidence on Condom Effectiveness for Sexually Transmitted Disease (STD) Prevention , 2001 .

[50]  D. Hendrie,et al.  The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis. , 2000, Health economics.

[51]  Margaret L. Brandeau,et al.  Who Do You Know ? A Simulation Study of Infectious Disease Control Through Contact Tracing , 2006 .

[52]  J. Robins,et al.  Transmission Dynamics and Control of Severe Acute Respiratory Syndrome , 2003, Science.

[53]  P. Bloomfield.  Update on emerging infections: news from the Centers for Disease Control and Prevention. Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. , 2007, Annals of emergency medicine.

[54]  Mirjam Kretzschmar,et al.  Ring Vaccination and Smallpox Control , 2004, Emerging infectious diseases.